ITMI921022A0 - Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale - Google Patents

Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale

Info

Publication number
ITMI921022A0
ITMI921022A0 IT92MI1022A ITMI921022A ITMI921022A0 IT MI921022 A0 ITMI921022 A0 IT MI921022A0 IT 92MI1022 A IT92MI1022 A IT 92MI1022A IT MI921022 A ITMI921022 A IT MI921022A IT MI921022 A0 ITMI921022 A0 IT MI921022A0
Authority
IT
Italy
Prior art keywords
blockers
procedure
preparation
active ingredient
oral administration
Prior art date
Application number
IT92MI1022A
Other languages
English (en)
Inventor
Istvan Racz
Sylvia Marton
Original Assignee
Synepos Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synepos Ag filed Critical Synepos Ag
Publication of ITMI921022A0 publication Critical patent/ITMI921022A0/it
Publication of ITMI921022A1 publication Critical patent/ITMI921022A1/it
Application granted granted Critical
Publication of IT1254953B publication Critical patent/IT1254953B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ITMI921022A 1992-03-13 1992-04-30 Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale IT1254953B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9200866A HU209251B (en) 1992-03-13 1992-03-13 Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US08/135,992 US5484776A (en) 1992-03-13 1993-10-14 Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration

Publications (3)

Publication Number Publication Date
ITMI921022A0 true ITMI921022A0 (it) 1992-04-30
ITMI921022A1 ITMI921022A1 (it) 1993-10-30
IT1254953B IT1254953B (it) 1995-10-11

Family

ID=26318071

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921022A IT1254953B (it) 1992-03-13 1992-04-30 Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale

Country Status (7)

Country Link
US (1) US5484776A (it)
DE (1) DE4212640A1 (it)
FR (1) FR2688405B1 (it)
GB (1) GB2264866A (it)
HU (1) HU209251B (it)
IT (1) IT1254953B (it)
SE (1) SE9201208L (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4331539A1 (de) * 1993-09-17 1995-03-23 Basf Ag Dextranester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Umhüllung oder Einbettung von Arzneimitteln
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
WO1995028916A1 (en) * 1994-04-25 1995-11-02 Edward Mendell Co., Inc. Sustained release excipient
AU2068797A (en) * 1996-01-29 1997-08-20 Edward Mendell Co. Inc. Sustained release excipient
JPH10139670A (ja) * 1996-11-11 1998-05-26 Terukuni Yakida インターロイキン１２誘導物質及び医薬組成物
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
RU2224523C2 (ru) 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
EP1255566A2 (en) * 2000-02-04 2002-11-13 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
EP1499295A4 (en) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co EXTENDED RELEASE METOPROLOL FORMULATIONS
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
DE602005019582D1 (de) * 2004-08-30 2010-04-08 Seo Hong Yoo Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
KR20070084211A (ko) * 2004-10-15 2007-08-24 유서홍 약제학적 화합물의 독성을 감소시키기 위한 방법 및 조성물
JP2008518935A (ja) * 2004-11-01 2008-06-05 セオ ホン ユー 筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
US9724297B2 (en) 2014-04-01 2017-08-08 Arbor Pharmaceuticals, Inc. Sotalol compositions and uses of the same
GB2593902B (en) 2020-04-07 2022-04-13 Actimed Therapeutics Ltd Salt of a pharmaceutical compound
CN116407495A (zh) * 2023-03-09 2023-07-11 北京梅尔森医药技术开发有限公司 一种阿替洛尔口服溶液及其制备方法和应用
WO2025068937A1 (en) 2023-09-30 2025-04-03 Liqmeds Worldwide Limited An oral liquid formulation of metoprolol
AU2024352372A1 (en) * 2023-09-30 2026-04-09 Liqmeds Worldwide Limited An oral liquid formulation of metoprolol

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (it) * 1962-01-24
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
SE441525B (sv) * 1978-05-19 1985-10-14 Ici Ltd P-hydroxifenylettiksyra
US4394390A (en) * 1979-08-03 1983-07-19 University Of Kentucky Research Foundation Nasal dosage forms of propranol
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
JPS59130866A (ja) * 1983-01-17 1984-07-27 Zeria Shinyaku Kogyo Kk ピンドロ−ル製剤の製造法
US4689235A (en) * 1984-01-31 1987-08-25 Scm Corporation Encapsulation matrix composition and encapsulate containing same
GB8402573D0 (en) * 1984-02-01 1984-03-07 Fisons Plc Oral formulation
US4579867A (en) * 1984-04-09 1986-04-01 American Hospital Supply Corporation Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
US4600708A (en) * 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
GB8522453D0 (en) * 1985-09-11 1985-10-16 Lilly Industries Ltd Chewable capsules
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4915949A (en) * 1987-07-13 1990-04-10 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
DE4004656C1 (it) * 1990-02-15 1991-05-02 Melitta Haushaltsprodukte Gmbh & Co Kg, 4950 Minden, De
US5100688A (en) * 1990-02-23 1992-03-31 Cox James P Saccharide/protein gel
US5225219A (en) * 1992-01-02 1993-07-06 The United States Of America, As Represented By The Secretary Of Agriculture Amylodextrin compositions and method therefor

Also Published As

Publication number Publication date
FR2688405B1 (fr) 1995-03-03
HU9200866D0 (en) 1992-05-28
SE9201208L (sv) 1993-09-14
FR2688405A1 (fr) 1993-09-17
US5484776A (en) 1996-01-16
GB9208518D0 (en) 1992-06-03
DE4212640A1 (de) 1993-09-16
GB2264866A (en) 1993-09-15
IT1254953B (it) 1995-10-11
HUT63580A (en) 1993-09-28
HU209251B (en) 1994-04-28
ITMI921022A1 (it) 1993-10-30
SE9201208D0 (sv) 1992-04-15

Similar Documents

Publication Publication Date Title
ITMI921022A0 (it) Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale
DE69323442D1 (de) Flüssige pharmazeutische Formulierung mit verlängerter Wirkstoffabgabe
CZ8193A3 (en) Pharmaceutical dosing form with prolonged release of active compound
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
IT1191674B (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
DE69434479D1 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
KR890701076A (ko) 온도-조절된 활성약제 디스펜서
DK583789A (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
ATE87471T1 (de) Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
DK98088D0 (da) Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel
AU2899592A (en) Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
FI891069A7 (fi) Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
AU1027792A (en) A pour-on formulation for the administration of anthelmintics
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
GB8901833D0 (en) Pharmaceutical formulations with controlled drug release
AU656199B2 (en) A pharmaceutical preparation containing a thrombolytically active substance
GR862457B (en) Pharmaceutical formulations with controlled release of the active substance
ITMI913335A0 (it) Sistema farmaceutico per la somministrazione a rilascio controllato di didropiridine terapeuticamente attive e metodo di preparazione
AU3961693A (en) Compositions and devices for the intrauterine administration of drugs
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950427